PHQ-9-Guided Ordinal Contrastive Learning for Severity-Aware EEG Depression Representation Learning
Bioengineering · 07.11.2026 · 13 (11) · 1322
DOI: 10.3390/bioengineering13111322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioengineering, online erschienen am 07.11.2026. Verfasst von Kholoud Elnaggar und 2 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Electroencephalography (EEG)-based depression detection studies commonly reduce clinical severity scores, such as the Patient Health Questionnaire-9 (PHQ-9), to binary diagnostic labels, thereby discarding ordinal information that may be useful for representation learning. This study proposes PHQ-9-guided ordinal contrastive learning (CE+OC), a training objective that uses PHQ-9 scores as privileged ordinal supervision during training while requiring only EEG at inference. PHQ-9 severity distances guide contrastive pair selection and scale the embedding separation margin, using clinical distances to guide the latent EEG space without an explicit patient-ranking objective. The method was evaluated on the Multi-modal Open Dataset for Mental-Disorder Analysis (MODMA) using strict leave-one-subject-out cross-validation across 53 subjects with 128-channel resting-state EEG. The primary representation finding was improved full-cohort PHQ-9 recoverability: a cross-validated held-out PHQ-9 probe showed that CE+OC increased recoverable PHQ-9 rank correlation from 7.8% to 33.6% (paired two-sided permutation p=0.031), an absolute gain of 25.7 percentage points, and reduced mean absolute PHQ-9 error from 27.8% to 22.8% of the 27-point PHQ-9 range (18.1% relative reduction; paired two-sided Wilcoxon p=0.011; bootstrap 95% CI for Δρ: 3.0% to 49.6%). CE+OC also showed descriptive diagnostic differences on MODMA: AUC increased from 59.8% to 69.3%, balanced accuracy from 59.5% to 66.0%, specificity from 69.0% to 86.2%, precision for major depressive disorder (MDD) from 57.1% to 73.3%, and MDD-F1 from 53.3% to 56.4%. False positives decreased from 31.0% to 13.8% of healthy subjects, although sensitivity decreased from 50.0% to 45.8%. A separate LOSO diagnosis evaluation on the independently acquired Mumtaz cohort achieved an AUC of 85.1%; it provides secondary evidence that the pipeline is feasible in a second cohort, but it is not a cross-dataset transfer experiment. A true-diagnosis-only control achieved ρ=0.502 and MAE 2.142 points, and within-MDD probe correlation remained negative (ρ=−0.424). The findings support increased full-cohort PHQ-9 recoverability relative to CE-only, not established information beyond diagnosis; diagnostic difference intervals include zero, and the model is not validated for stand-alone screening.
Zitieren
APA
Elnaggar, K., El-Gayar, M. M., & Elmogy, M. (2026). PHQ-9-Guided Ordinal Contrastive Learning for Severity-Aware EEG Depression Representation Learning. Bioengineering, 13(11), 1322. https://doi.org/10.3390/bioengineering13111322
Vancouver
Elnaggar K, El-Gayar MM, Elmogy M. PHQ-9-Guided Ordinal Contrastive Learning for Severity-Aware EEG Depression Representation Learning. Bioengineering. 2026;13(11):1322. doi:10.3390/bioengineering13111322
BibTeX
@article{Elnaggar2026,
author = {Elnaggar, Kholoud and El-Gayar, Mostafa M. and Elmogy, Mohammed},
title = {PHQ-9-Guided Ordinal Contrastive Learning for Severity-Aware EEG Depression Representation Learning},
journal = {Bioengineering},
year = {2026},
volume = {13},
number = {11},
pages = {1322},
doi = {10.3390/bioengineering13111322}
}
EUVIMED